Literature DB >> 15264193

Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis.

Dulce Barbosa1, Lidimara Lima, Suzane Silbert, Hélio Sader, Miguel Cendoroglo, Sergio Draibe, Luis Camargo, Lucila Vianna, Angelica Belasco, Ricardo Sesso.   

Abstract

BACKGROUND: Vancomycin-resistant Enterococcus (VRE) has been reported among long-term dialysis patients, although risk factors for VRE colonization are not well defined. This study aims to appraise the prevalence and risk factors for VRE colonization among patients on long-term dialysis therapy, as well as the mechanisms for dissemination of vancomycin resistance.
METHODS: This is a cross-sectional survey of 320 patients on long-term dialysis therapy at 2 hospitals of the Federal University of São Paulo from June 2001 to March 2003. Fecal samples were collected from each patient once a week for 1 month. Samples with positive test results for VRE were submitted to molecular typing through automated ribotyping.
RESULTS: VRE prevalence was 14.4%. There were significant associations between VRE and dialysis type (hemodialysis, P = 0.04), number of hospitalizations (P = 0.03), low hemoglobin level (P = 0.03), and leukocytosis (P = 0.05). Among samples with VRE (n = 56), 25% were Enterococcus faecium; 10.7%, Enterococcus casseliflavus; 57.1%, Enterococcus gallinarum; and 3.6%, Enterococcus faecalis. All samples isolated were sensitive to teicoplanin, except for E faecium samples, which were strongly resistant, although 9 of 14 patients with this isolate presented the same ribogroup (111-S-4). Typing of 6 samples from 8 dialysis patients with E gallinarum was performed, showing a predominant ribogroup (112-S-4).
CONCLUSION: Hospital environment, hemodialysis, anemia, and leukocytosis appear to be associated with VRE colonization. These results suggest that dissemination of these bacteria among patients on long-term dialysis therapy may be taking place.

Entities:  

Mesh:

Year:  2004        PMID: 15264193     DOI: 10.1053/j.ajkd.2004.04.038

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

2.  Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.

Authors:  In Ji Song; Ji Won Seo; Young Eun Kwon; Young Ly Kim; Tae Seop Lim; Ea Wha Kang; Tae Ik Chang
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

3.  Impact of the reduction of environmental and equipment contamination on vancomycin-resistant enterococcus rates.

Authors:  M R E Perugini; S M Nomi; G K Lopes; R A Belei; I M van der Heijden; A K Q Mostachio; C Grion; E B Couto; S F Costa
Journal:  Infection       Date:  2011-08-17       Impact factor: 3.553

4.  Urinary tract infections in renal transplant recipients.

Authors:  George Alangaden
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

5.  Infected prosthetic dialysis arteriovenous grafts: a single dialysis center study.

Authors:  Petr Bachleda; Lucie Kalinova; Petr Utikal; Milan Kolar; Kristyna Hricova; Tatana Stosova
Journal:  Surg Infect (Larchmt)       Date:  2012-12-10       Impact factor: 2.150

6.  Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.

Authors:  Maria Cecília S Freitas; Alvaro Pacheco-Silva; Dulce Barbosa; Suzane Silbert; Hélio Sader; Ricardo Sesso; Luis Fernando A Camargo
Journal:  BMC Infect Dis       Date:  2006-08-22       Impact factor: 3.090

7.  Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center: a case-control study.

Authors:  Dayana Fram; Meiry Fernanda Pinto Okuno; Mônica Taminato; Vinicius Ponzio; Silvia Regina Manfredi; Cibele Grothe; Angélica Belasco; Ricardo Sesso; Dulce Barbosa
Journal:  BMC Infect Dis       Date:  2015-03-26       Impact factor: 3.090

8.  Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006).

Authors:  S Shaghaghian; B Pourabbas; A Alborzi; M Askarian; J Mardaneh
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

9.  Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.

Authors:  Ojan Assadian; Mehrdad Askarian; Maria Stadler; Soheila Shaghaghian
Journal:  BMC Infect Dis       Date:  2007-06-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.